MedPath

Effects of open- and closed label nocebo and placebo verbal suggestions on itch

Completed
Conditions
Het onderzoek wordt bij gezonde proefpersonen uitgevoerd. Uitkomsten uit deze lijn van onderzoek bieden nieuwe handvatten voor verklaringsmodellen en therapeutische interventies voor aandoeningen waarbij jeuk een symptoom is.
Not applicable
Registration Number
NL-OMON43008
Lead Sponsor
niversiteit Leiden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
92
Inclusion Criteria

Between 18 and 35 years old; good understanding of written and spoken Dutch

Exclusion Criteria

Refusal to give written informed consent; severe somatic or psychological morbidity (e.g., heart and lung diseases or DSM-IV psychiatric disorders) that would adversely affect participant's safety or that might interfere with the study protocol; current chronic itch or pain complaints; current use of analgesics, anti-inflammatory drugs, antihistamines, antibiotics or recent vaccinations; pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary study parameter is self-reported itch during histamine<br /><br>iontophoresis. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary study outcomes include wheal size, flare response, skin temperature,<br /><br>and self-reported skin condition following histamine iontophoresis, as well as<br /><br>scratching behaviour. In addition, the possible influence of psychological<br /><br>parameters on outcomes will be explored.</p><br>
© Copyright 2025. All Rights Reserved by MedPath